However, the regulatory mechanisms of GPR137C in the gastric cancer tumor immune microenvironment and the targeting specificity and clinical efficacy of the potential drugs require further investigation and discovery through our future research efforts. The gene discussed is GPR137C; the disease is gastric cancer.